Peter Konturek, Thomas Hess. Show Affiliations »
Abstract
Mesh： See more » Administration, OralAgedAnticoagulants/adverse effectsAnticoagulants/therapeutic useArthroplasty, Replacement, HipArthroplasty, Replacement, KneeAtrial Fibrillation/complicationsAtrial Fibrillation/drug therapyBenzimidazoles/adverse effectsBenzimidazoles/therapeutic useCerebral Hemorrhage/chemically inducedCerebral Hemorrhage/prevention & controlDabigatranGastrointestinal Hemorrhage/chemically inducedGastrointestinal Hemorrhage/prevention & controlHumansIntracranial Embolism/etiologyIntracranial Embolism/prevention & controlMorpholines/adverse effectsMorpholines/therapeutic usePostoperative Complications/prevention & controlPyrazoles/adverse effectsPyrazoles/therapeutic usePyridones/adverse effectsPyridones/therapeutic useRisk FactorsRivaroxabanThiophenes/adverse effectsThiophenes/therapeutic useThrombosis/prevention & controlVitamin K/antagonists & inhibitorsWarfarin/adverse effectsWarfarin/therapeutic usebeta-Alanine/adverse effectsbeta-Alanine/analogs & derivativesbeta-Alanine/therapeutic use
Substances： See more » AnticoagulantsBenzimidazolesMorpholinesPyrazolesPyridonesThiophenesbeta-AlanineVitamin KapixabanWarfarinRivaroxabanDabigatran
Year: 2014 PMID： 24934056 DOI： 10.1007/s15006-014-2599-4
Source DB: PubMed Journal: MMW Fortschr Med ISSN： 1438-3276